Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure

Table 2

Baseline characteristics of HBV-ACLF patients who survived during the 180-day follow-up and those who died.

Characteristics	Survived ( = 35)	Died ( = 13)	Statistic	value
Sex, male : female	33 : 2	12 : 1
Age, years	37.91 ± 9.00	39.62 ± 10.93	= −0.549	0.586
ALT, U/L; (median, IQR)	531.00; (266.00–1262.00)	92.00; (67.00–393.00)	= −3.631	0.000
TBIL, umol/L (  ± SD)	317.29 ± 169.24	502.92 ± 184.08	= −3.312	0.002
INR; (median, IQR)	1.78; (1.57–2.00)	3.00; (2.32–4.30)	= −3.666	0.000
HBV DNA (/mL,  ± SD)	5.85; (4.85–8.20)	5.73; (4.02–6.28)	= −1.090	0.272

ALT, alanine aminotransferase; INR, prothrombin time international normalized ratio; IQR, 25%–75% interquartile range; NA, not applicable; TBIL, total bilirubin. -values for differences between two groups were determined with Student’s -test for parameter data and Mann-Whitney test for nonparametric data.